TY - JOUR
T1 - Variation in expression of S3 antigen in human sarcoma cell lines
T2 - Influence of passages and medium on generation of S3
AU - Sethi, Jitender K.
AU - Hirshaut, Yashar
N1 - Funding Information:
In a'RE investigation of human tumor associated antigens, tissue culture cell lines have frequently served as the principal sources of antigen. Among the antigens which have been detected in cultured human cells are those related to melanoma [1, 2], sarcoma [3-8], Hodgkin's disease [9] and gliomas [10]. Unfortunately, in most instances antigen expression is quite variable. Often the antigen is expressed only for a short period, during a single passage or several early passages, and then seems to disappear. In this paper, our efforts to study antigen expression over a several month period in human sarcoma cell lines is reported. In this way, it was hoped to gain added insight into the basis for variation in tumor antigen expression Accepted 19 April 1978. *The authors gratefully acknowledge the support of the National Cancer Institute through contract No. N01-CB-53942. tAddress tbr reprints: Dr. Jitender Sethi, Sloan-Kettering Institute for Cancer Research, 425 East 68th St., New York, NY 10021.
PY - 1978/11
Y1 - 1978/11
N2 - An antigen S3, common to human sarcomas, has been detected by complement-fixation methods in sarcoma cell cultures (JNCI 57:489, 1976). Initial observations suggested that S3 was present only during passages 1-3 and uniformly absent in older cell lines. This study was undertaken to determine the constancy of expression of S3 in repeated passages in S3-bearing cell lines. In addition, the influence of trypsinization and feeding on S3 production were studied. Cell cultures prepared from 2 fibrosarcomas and chondrosarcoma were studied indetail in this regard. At each passage a sample was taken for cytological examination and another to determine whether S3 was present. Expression of S3 antigen was found to be extremely variable and no change in the distribution of cell types, morphologically identified, was noted, regardless of culture conditions and passage. The study confirms that S3 antigen is most consistently expressed in early passages of human sarcoma cell lines and that this antigen may reappear in passages even if absent for as long as 4 serial passages. The variability of antigen production cannot be attributed to details of the trypsinization procedures used, the presence or absence of cell products in the medium used, or to the selection of specific cell types in the culture with the passage of time.
AB - An antigen S3, common to human sarcomas, has been detected by complement-fixation methods in sarcoma cell cultures (JNCI 57:489, 1976). Initial observations suggested that S3 was present only during passages 1-3 and uniformly absent in older cell lines. This study was undertaken to determine the constancy of expression of S3 in repeated passages in S3-bearing cell lines. In addition, the influence of trypsinization and feeding on S3 production were studied. Cell cultures prepared from 2 fibrosarcomas and chondrosarcoma were studied indetail in this regard. At each passage a sample was taken for cytological examination and another to determine whether S3 was present. Expression of S3 antigen was found to be extremely variable and no change in the distribution of cell types, morphologically identified, was noted, regardless of culture conditions and passage. The study confirms that S3 antigen is most consistently expressed in early passages of human sarcoma cell lines and that this antigen may reappear in passages even if absent for as long as 4 serial passages. The variability of antigen production cannot be attributed to details of the trypsinization procedures used, the presence or absence of cell products in the medium used, or to the selection of specific cell types in the culture with the passage of time.
UR - http://www.scopus.com/inward/record.url?scp=0018039223&partnerID=8YFLogxK
U2 - 10.1016/0014-2964(78)90229-3
DO - 10.1016/0014-2964(78)90229-3
M3 - Article
C2 - 570108
AN - SCOPUS:0018039223
SN - 0014-2964
VL - 14
SP - 1229
EP - 1235
JO - European Journal of Cancer (1965)
JF - European Journal of Cancer (1965)
IS - 11
ER -